NEW DELHI (Reuters) - India on Sunday banned the export of anti-viral drug Remdesivir and its active pharmaceutical ingredients as demand rocketed due to a record surge in COVID-19 infections, leading to a crippling shortages in many parts. Authorities have blamed the ferocious resurgence of the virus mainly on crowding and a reluctance to wear masks. Still, religious gatherings have continued and Prime Minister Narendra Modi and Home Minister Amit Shah have themselves addressed election campaigns attended by tens of thousands of people, many without masks and hardly any following social distancing. As new COVID-19 cases surged to 152,879 on Sunday, the sixth record rise in seven days, harried relatives of patients made a kilometre-long queue to buy Remdesivir outside a big hospital in the western state of Gujarat, witnesses said. India, known as the pharmacy of the world, has already stalled major exports of coronavirus vaccines though its supply too has run short in some ... » Learn More about India bans Remdesivir exports as coronavirus rages on; rallies continue
Pm narendra modi email address
China administers 164.47 million COVID-19 vaccinations as of April 10
China has administered 164.47 million doses of COVID-19 vaccines as of Saturday, the National Health Commission said on Sunday. This represents around 24.5 million doses in the past six days, as the country's vaccine rollout continues to accelerate. Last week a Chinese official said the country is expected to produce around 3 billion doses of COVID-19 vaccines by the end of the year. Chinese health authorities on Sunday reported 10 new confirmed cases of COVID-19 and 22 asymptomatic cases, bringing the country's total to 90,410, while the death toll remained unchanged at 4,636. The National Health Commission, in a statement, said all the new cases were imported infections originating from overseas. The number of new asymptomatic cases, which China does not classify as confirmed cases, rose to 22 from 11 cases a day earlier. The total number of confirmed COVID-19 cases in Mainland China now stands at 90,410, while the death toll remained unchanged at 4,636. Meanwhile, in ... » Learn More about China administers 164.47 million COVID-19 vaccinations as of April 10
Climate change: The other crisis we can’t ignore
It is difficult to concern ourselves with the effects of climate change, observable and tangible as they are, when so many are struggling to find medical care for their loved ones during this resurgent coronavirus disease 2019 (Covid-19) pandemic. The challenge of our time is having to face two equally serious crises, both with tremendous impact on human lives and no quick, easy fixes. And yet it is imperative that we keep an eye on our climate-related goals even as we work to manage the current health crisis because the problem is too big to set aside. Over the last few years, businesses have increasingly prioritized their sustainability initiatives as climate-related disasters drove home the magnitude of the crisis. Their efforts will continue to be crucial in mitigating the worst impacts of climate change. Recently, for example, news came out that only three companies are responsible for 46 percent of packaging waste found in the Philippines following a global brand audit of ... » Learn More about Climate change: The other crisis we can’t ignore